News

Get the latest on BIO's announcements, positions and views on everything from healthcare to biofuels. 

Press Releases
"Build Back Better Act" Drug Pricing Provisions…
Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement after the House of Representatives passed the Build Back Better Act: “The legislation that passed the House today…
Patients Empowered with New “Clinical Trials: The…
The Biotechnology Innovation Organization (BIO) today announced the launch of Clinical Trials: The Power of Participation (CTPoP), a website that addresses how clinical trials work, how to enroll in a clinical trial, and what to expect as a clinical…
White House’s “Build Back Better” Plan Builds New…
Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), made the following statement: "Last week, Democratic leaders announced they had reached a drug pricing “deal.” We wanted to see the details before…
Letters, Testimony, & Comments
BIO Comments on Draft Guidance: Reporting Amount…
On Wednesday, December 29th, BIO submitted comments to the Food and Drug Administration’s recent draft guidance for industry entitled, Reporting Amount of Listed Drugs and Biological Products Under Section 510(j)(3) of the Federal Food, Drug, and…
BIO Comments on Draft Guidance: Q13 Continuous…
On Monday, December 13th, BIO submitted comments to the Food and Drug Administration’s recent draft guidance for industry entitled, Q13 Continuous Manufacturing of Drug Substances and Drug Products. The draft guidance was prepared under the auspices…
BIO Joins Letter to FDA Commissioner on…
New innovations capable of advancing plant breeding, such as gene editing, have immense potential to improve agriculture and food production. Researchers are exploring genetic innovations aimed at increasing agricultural productivity; improving…
Amicus Briefs
BIO Files Amicus Brief in Petition for a Writ of…
BIO and AUTM have filed an amicus brief in petition for a writ of certiorari the in American Axle & Manufacturing, Inc., v. Neapco Holdings LLC, et al., at the Supreme Court of the United States. BIO and AUTM are concerned that…
BIO Files Amicus Brief in Support of Rehearing…
BIO files amicus brief in support of a petition for rehearing related to patent-eligibility of diagnostic technology. 
BIO Files Amicus Brief on Case Addressing the…
BIO files an Amicus Brief on rehearing by the Precedential Opinion Panel of the Patent Trial and Appeal Board.
Blog Posts
BTN-MTC_Patient-Pharmacy.png
January 7, 2022
It’s a new calendar year – yet the tired drug pricing control policies of 2021 continue to float around Capitol Hill. Proponents of price controls justify their actions by claiming drug prices are “skyrocketing” and…
Covid Vaccine
December 22, 2021
As the world contends with the rapidly spreading Omicron variant of COVID-19, getting more people vaccinated and boosted is all the more essential. Unfortunately, however, many state legislatures have presented a slew…
carbon plants
December 16, 2021
2021 is shaping up to have been either the sixth or seventh hottest year on record. At the heart of this historically hot year is the amount of greenhouse gases that have been produced over the course of the year. One…